Skip to content

Controlling Anxiety in Late Life

Controlling Anxiety in Late Life

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON29127
Enrollment
240
Registered
2017-03-21
Start date
2017-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety complaints in the elderly

Interventions

The web-based intervention Living to the full is based on the Acceptance and Commitment Therapy-based selfhelp intervention ‘Living to the full'. The program consists of nine lessons to be completed

Sponsors

Initiator: Leiden University, Leiden University Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: (a) presence of mild to moderate anxiety symptoms, operationalized as a score between 4 and 15 on the GAD-7 (b) age between 55 and 75 years; (c) having internet-access; (d) able to invest approximately 30 minutes per day up to three hours per week; (e) able to communicate in Dutch.

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: (a) persons with severe anxiety (GAD-7 > 15) and/or depressive symptomatology (PHQ-9 score > 20); (b) at least two areas of role functioning with severe role impairment (SDS > 8); NL59034.058.16/ Controlling Anxiety in Late Life Version number: 1, 18-10-2016 13 of 38 (c) few anxiety (< 4 on the GAD-7) symptoms; (d) receiving psychological or psychopharmacological (with the exception of stable benzodiazepine or SSRI use) treatment for emotional complaints within the last 3 months; (e) lifetime diagnosis of bipolar disorder or schizophrenia; (f) high suicide risk; (g) dementia or other severe cognitive impairments; (h) unstable severe medical condition; (i) dependence on drugs or alcohol.

Design outcomes

Primary

MeasureTime frame
Severity of symptoms of anxiety will be assessed with the GAD-7

Secondary

MeasureTime frame
Depressive symptoms (PHQ-9) Presence of psychiatric disorder (M.I.N.I.-PLUS) Functional Impairment (SDS) Cognitive Emotion Regulation (CERQ) Mindfulness facets (FFMQ-SF) Experiental avoidance (AAQ-II) Positive mental health (MHC-SF) Quality of Life (EQ-5D) Medical consumption and productivity loss (TIC-P)

Contacts

Public ContactMaartje Witlox

Leiden University, Faculty of Social Sciences, Clinical Psychology

m.witlox@fsw.leidenuniv.nl-

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)